Featured Bioactive Ingredients & Formulation Bases
Explore certified high-purity botanicals, bioactive enzymes, and clinical-grade extracts engineered to complement marine lipid and metabolic longevity formulations.
Executive Technical Monograph: Antarctic Krill Bioactive Lipids
A comprehensive industrial assessment of Phospholipid-bound Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA), Esterified Astaxanthin, and Choline matrix delivery mechanisms.
Phospholipid Structural Superiority
Unlike standard trigylceride-bound marine fish oils or synthetic ethyl-ester conjugates, raw Antarctic Megared Krill Oil extracts feature long-chain polyunsaturated fatty acids naturally esterified to a phosphatidylcholine backbone. This biological structural alignment facilitates instantaneous water dispersibility, gastric phase-inversion resistance, and significantly bypassed biliary emulsification stages, accelerating direct transmembrane lymphatic uptake.
Integrated Choline & Astaxanthin Matrix
Every metric ton refined within our primary solvent-free isolation infrastructure retains endogenous free and esterified astaxanthin exceeding 1,000–1,500 ppm, alongside native trimethyl-based choline (>50 mg/g). Astaxanthin acts as a self-stabilizing lipophilic antioxidant umbrella, guarding sensitive unsaturated bonds against oxidative peroxidative decay without reliance on secondary synthetic preservatives or added alpha-tocopherols.
Clinical Bioavailability Index
Peer-reviewed pharmacokinetics demonstrate that phospholipid-associated EPA/DHA molecules integrate into target erythrocyte and myocardial cell membranes up to 2.5× more efficiently than standard marine fish oils over identical dosing cycles. This pharmacokinetic edge minimizes therapeutic dosage bulk, eliminates noxious reflux ("fishy repeating"), and allows seamless formulation within micro-softgels, enteric capsules, and functional beverage emulsions.
Standardized Export Grade Quality Framework
Strict batch-to-batch consistency verified via High-Performance Liquid Chromatography (HPLC), 31P-NMR spectroscopy, and Inductively Coupled Plasma Mass Spectrometry (ICP-MS).
| Analytical Parameter | Commercial Grade (PL40) | Clinical Grade (PL50/PL56) | Test Methodology Verification |
|---|---|---|---|
| Total Phospholipids | ≥ 40.0% w/w | ≥ 50.0% – 56.0% w/w | Quantitative 31P-NMR / Acetone Insolubles |
| Total Omega-3 Fatty Acids | ≥ 22.0% | ≥ 27.0% – 30.0% | Gas Chromatography (AOCS Ce 1b-89) |
| Eicosapentaenoic Acid (EPA) | ≥ 12.0% | ≥ 15.0% – 16.0% | USP 43 / Ph. Eur. Monograph 2642 |
| Docosahexaenoic Acid (DHA) | ≥ 6.5% | ≥ 7.5% – 9.0% | USP 43 / Ph. Eur. Monograph 2642 |
| Esterified Astaxanthin | ≥ 400 mg/kg (ppm) | ≥ 1,000 – 1,500 mg/kg (ppm) | Reverse-Phase HPLC (470 nm Photodiode) |
| Trimethylamine (TMA) / Peroxide Value | < 5.0 mg N/100g / < 3.0 meq/kg | < 2.5 mg N/100g / < 1.5 meq/kg | Colorimetric Determination / AOCS Cd 8b-90 |
| Heavy Metals (Pb, As, Cd, Hg) | < 0.1 ppm individual threshold | < 0.01 ppm High-Precision Ultra-Clean | ICP-MS Multi-Elemental Profiling |
Localized Cross-Industry Application Framework
Engineering high-stability krill lipid formulas customized to unique regional regulatory constraints, consumer swallowing preferences, and clinical delivery demands.
Cardiovascular & Endothelial Homeostasis
Tailored extensively for the North American and Western European aging populations. OEM krill oil formulations target systemic inflammation reduction (hs-CRP suppression), maintenance of normal arterial elasticity, and optimized serum triglyceride clearance without elevating circulating low-density lipoprotein (LDL-C) profiles.
Neuro-Cognitive Longevity & Synaptic Density
Targeted heavily across developed Asian economies (Japan, South Korea, Singapore) facing rapidly shifting demographics. Because krill phospholipids naturally mimic the phospholipid architecture of cortical neuronal sheaths, dietary intake directly supports synaptic acetylcholine production, memory retention, and microvascular cerebral perfusion.
Nutricosmetics & Cellular Photoprotection
Rapidly expanding demand across Southeast Asia, Latin America, and the Middle East for systemic oral suncare and dermato-barrier reinforcement. Endogenous astaxanthin acts as an active biological internal screen against UV-induced dermal matrix degradation, preventing collagenase upregulation and improving epidermal skin elasticity and hydration.
Sports Muscle Recovery & Arthritic Joint Comfort
Formulated for performance athletes and active lifestyle brackets requiring rapid attenuation of exercise-induced delayed onset muscle soreness (DOMS). Phospholipid-bound EPA actively limits the cellular cascade of pro-inflammatory eicosanoids (prostaglandin E2, leukotriene B4), promoting cartilage lubrication and accelerated physical recovery times.
Chinese Manufacturing Resilience & Global Supply Velocity
How our state-of-the-art 60,000 square meter industrial processing complex delivers unyielding cost efficiency, volume scalability, and geopolitical freight resilience.
End-to-End Extraction Infrastructure
Our extraction facilities operate six specialized continuous-flow multi-tank refining trains. Sourcing frozen krill biomass directly from certified Antarctic harvesting vessels operating in CCAMLR Area 48, our onshore processing combines low-temperature subcritical extraction with closed-loop solvent recovery, mitigating thermal lipid oxidation and maintaining intact biomolecular integrity.
Cost Scaling Without Purity Compromise
By leveraging domestic mechanical automation, proprietary nitrogen-purged processing loops, and integrated localized cold-chain logistics, our cost-per-kilogram footprint is dramatically lower than legacy Western contract facilities. Brand partners capture 30% to 45% margin expansions while preserving identical or superior active compound specifications.
Export Buffer & Continuous Inventory
Supply chain shocks cripple single-source brands. We maintain an active rolling buffer of over 200 metric tons of standardized raw krill crude and refined phospholipid bases at climate-controlled central hubs, guaranteeing lead times under 14 business days to any major deepwater maritime transport terminal.
Global Industry Landscape & Supply Modernization
Navigating environmental fishing quotas, market demand migration toward high-potency marine lipids, and consumer transparency imperatives.
Ecological Catch Stewardship (CCAMLR)
Antarctic krill harvest operations are strictly monitored under the Commission for the Conservation of Antarctic Marine Living Resources (CCAMLR). Total allowable catch thresholds are fixed at less than 1% of the unexploited biomass in Sector 48, establishing krill lipid manufacturing as one of the most environmentally regulated, fully verifiable marine resource supply systems in global bio-commerce.
The Consumer Pivot Away from Standard Fish Oil
Global consumer dissatisfaction with conventional concentrated fish oils—stemming from rancid off-notes, gastrointestinal reflux, microplastic contamination anxieties, and unsustainable pelagic overfishing—has driven annual compounding demand for clean-origin Antarctic krill oil across sports nutrition, pharmaceutical adjunctive, and wellness retail ecosystems.
Full Batch Traceability Protocols
Modern B2B enterprise procurement demands granular tracking from ocean capture coordinates to finished softgel packaging. Our production protocols log vessel IMO identifications, GPS harvest coordinates, flash-freezing timestamps, onshore extraction batch tags, and third-party spectroscopic verifications into unalterable, fully auditable digital supply ledgers.
R&D Horizons & Advanced Marine Lipid Engineering
Pioneering clean-tech extraction methodologies, liposomal dispersion systems, and high-potency microencapsulation technologies.
Supercritical CO₂ & Ethanol Co-Extraction
Transitioning beyond legacy hydrocarbon or purely ethanolic isolation systems, our pilot engineering lines have achieved industrial implementation of multi-stage Supercritical CO₂ combined with food-grade anhydrous ethanol co-solvents. This yields a transparent, low-viscosity krill oil with virtually undetectable volatile organic residues (< 1 ppm), exceptionally low odor profiles, and pristine phospholipid preservation.
Microencapsulated Cold-Water Soluble Powders
Traditional lipid softgels limit functional formulation flexibility. Our materials scientists have industrialized advanced spray-granulation and double-liposome microencapsulation matrices. This converts high-phospholipid krill oil into a free-flowing, fully water-soluble red powder, enabling clear ready-to-mix (RTM) stick packs, nutritional sachets, meal replacements, and dry functional beverage applications.
Synergistic Functional Stacking Blends
Modern formulators are actively phasing out monocomponent softgels in favor of targeted multifunctional stacks. Leveraging our expansive ingredient capabilities, we deliver premixed, homogenized, and encapsulated blends combining Phospholipid Krill Lipids with botanical actives such as Nattokinase, Safflower CLA, Marine Collagen Peptides, and Coenzyme Q10 for superior clinical synergy.
Regulatory Harmonization & International Compliance
Exhaustive documentation packages and third-party laboratory qualifications designed to accelerate market entry across stringent sovereign regulatory bodies.
United States FDA 21 CFR Part 111
Fully compliant with US cGMP guidelines for dietary supplements. Full support for New Dietary Ingredient (NDI) notifications, Generally Recognized as Safe (GRAS) affirmation documentation, Proposition 65 heavy metal compliance clearances, and foreign supplier verification program (FSVP) documentation.
European Union EFSA Novel Food Clearance
Aligned precisely with European Union Regulation (EU) 2015/2283 for Novel Foods and Regulation (EC) 1881/2006 setting maximum levels for contaminants. Batch analysis verifies non-detectable levels for Dioxins, Dioxin-like PCBs, Polycyclic Aromatic Hydrocarbons (PAH4), and Benzo(a)pyrene.
Global Halal & Kosher Certification
Our extraction facilities and dedicated softgel encapsulation suites maintain validated annual Halal (JAKIM/MUI recognized) and Kosher certifications. We offer porcine-free bovine pharmaceutical gelatin or 100% vegetarian seaweed-derived carrageenan softgel shells to serve diverse consumer demographics.
Frequently Asked Technical Questions
Direct answers addressing formulation stability, shell compatibility, minimum order parameters, and custom encapsulation workflows.
What distinguishes Megared Krill Oil Ingredients from generic crude marine oils?
Our OEM Megared Krill Oil ingredient profiles represent refined, pharmaceutical-grade marine lipid complexes derived exclusively from Antarctic Euphausia superba. The EPA and DHA content is naturally bound to amphiphilic phospholipids (principally phosphatidylcholine), enabling rapid gastrointestinal emulsification, superior intracellular transport, and superior cellular uptake without the heavy fishy burps associated with ethyl ester or basic triglyceride marine oils. Furthermore, endogenous levels of active astaxanthin preserve fatty acid freshness without requiring artificial synthetic stabilizers.
How does your factory prevent softgel degradation, leaking, and cross-linking?
High phospholipid oils can be hygroscopic, which poses unique challenges for standard softgel shell integrity. Our manufacturing plants resolve this through proprietary atmospheric moisture controls, vacuum deaeration of the fill matrix, and specialized gelatin/carrageenan plasticizer ratios. We also incorporate strict thermal profiling during drying cycles to ensure shell elasticity, entirely preventing brittle shell fracturing, weeping, cross-linking, or micro-leaks throughout a 24- to 36-month stability shelf life.
What custom OEM/ODM packaging and encapsulation formats are supported?
We provide comprehensive turnkey private label solutions. Capabilities include bulk oil supply in nitrogen-blanketed 25kg and 190kg steel drums; custom softgel encapsulation ranging from 300mg to 1,200mg (oval, oblong, or round shapes in standard gelatin, enteric-coated, or vegetarian plant-based shells); and finished consumer-ready packaging including amber PET/HDPE bottles, blister packs, outer carton printing, and custom-branded stick-pack powders.
What are the typical Minimum Order Quantities (MOQ) and fulfillment lead times?
For standardized bulk raw krill oil ingredients (PL40 to PL56), our standard MOQ is 25 kg. For custom OEM private label softgel encapsulation, our production runs start at 300,000 units. Bulk ingredient orders ship within 5 to 7 business days from ready domestic warehouse inventories; turnkey custom-branded softgel production orders typically deliver within 3 to 4 weeks, including analytical batch COA sign-offs.
What regulatory and quality documentation is provided with every shipment?
Every commercial consignment includes a verified comprehensive Certificate of Analysis (COA) specifying phospholipid assay (via 31P-NMR), EPA/DHA breakdown, astaxanthin concentration, microbiological profiles, and heavy metal testing. Additionally, we provide multi-language Safety Data Sheets (SDS), technical product specification sheets, non-GMO statements, BSE/TSE-free declarations, allergen declarations, and CCAMLR catch certification provenance upon request.
Bio-Compatible Fine Chemicals & Active Ingredients
Explore complementary nutraceutical and personal care ingredients engineered for high-performance formulation synergies.
